Long-term health hazards from diagnostic X-ray exposure by Nordenskjöld, Arvid
Thesis for doctoral degree (Ph.D.)
2018
Long-term health hazards from 
diagnostic X-ray exposure
Arvid Nordenskjöld
A
rvid
 N
o
rd
en
skjö
ld
Long-term
 health hazards from
 diagnostic X-ray exposure
From DEPARTMENT OF MEDICINE, SOLNA 
CLINICAL EPIDEMIOLOGICAL UNIT 
Karolinska Institutet, Stockholm, Sweden 
LONG-TERM HEALTH HAZARDS FROM 
DIAGNOSTIC X-RAY EXPOSURE 
Arvid Nordenskjöld 
 
Stockholm 2018 
 
From DEPARTMENT OF MEDICINE, SOLNA 
CLINICAL EPIDEMIOLOGICAL UNIT 
Karolinska Institutet, Stockholm, Sweden 
LONG-TERM HEALTH HAZARDS FROM 
DIAGNOSTIC X-RAY EXPOSURE 
Arvid Nordenskjöld 
 
Stockholm 2018 
 
1
 All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by E-print AB 2018 
© Arvid Nordenskjöld, 2018 
ISBN 978-91-7831-128-6 
 
All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by E-print AB 2018 
© Arvid Nordenskjöld, 2018 
ISBN 978-91-7831-128-6 
2
Long-term health hazards from diagnostic X-ray 
exposure 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Arvid Nordenskjöld 
Principal Supervisor: 
Dr Magnus Kaijser 
Karolinska Institutet 
Department of Medicine, Solna 
Division of Clinical Epidemiology Unit  
 
Co-supervisor(s): 
Fredrik Granath 
Karolinska Institutet 
Department of Medicine, Solna 
Division of Clinical Epidemiology Unit 
 
Peter Aspellin 
Karolinska Institutet 
Department of Clinical Science, Intervention and 
Technology 
Division of Radiology 
 
 
 
 
  
Opponent: 
Joachim Schüz 
International Agency for Research on Cancer, 
Lyon, France 
Section of Environment and Radiation 
 
 
Examination Board: 
Lars Holmberg 
Uppsala Universitet 
Department of Surgical Sciences 
King’s College, London, United Kingdom 
Faculty of Life Sciences and Medicine 
 
Marie Lundell 
Karolinska Institutet 
Department of Oncology-Pathology 
 
Johan Wikström 
Uppsala Universitet 
Department of Surgical Sciences, Radiology 
 
 
Presented at 10 o’clock a.m. on Friday the 14th of September 2018 
At Ulf von Euler J3:06, NKS, Solnavägen 30
Long-term health hazards from diagnostic X-ray 
exposure 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Arvid Nordenskjöld 
Principal Supervisor: 
Dr Magnus Kaijser 
Karolinska Institutet 
Department of Medicine, Solna 
Division of Clinical Epidemiology Unit  
 
Co-supervisor(s): 
Fredrik Granath 
Karolinska Institutet 
Department of Medicine, Solna 
Division of Clinical Epidemiology Unit 
 
Peter Aspellin 
Karolinska Institutet 
Department of Clinical Science, Intervention and 
Technology 
Division of Radiology 
 
 
 
 
  
Opponent: 
Joachim Schüz 
International Agency for Research on Cancer, 
Lyon, France 
Section of Environment and Radiation 
 
 
Examination Board: 
Lars Holmberg 
Uppsala Universitet 
Department of Surgical Sciences 
King’s College, London, United Kingdom 
Faculty of Life Sciences and Medicine 
 
Marie Lundell 
Karolinska Institutet 
Department of Oncology-Pathology 
 
Johan Wikström 
Uppsala Universitet 
Department of Surgical Sciences, Radiology 
 
 
Presented at 10 o’clock a.m. on Friday the 14th of September 2018 
At Ulf von Euler J3:06, NKS, Solnavägen 30
3
4
  
 
 
For Science! 
  
 
 
 
 
For Science! 
  
5
  
 
 
6
  
ABSTRACT 
Medical imaging is an important function in the diagnosis and management of disease and its use have 
been increasing with technological advancements. A large part of medical imaging uses ionizing 
radiation as medium for imaging although it does pose potential risks to the patient. Computed 
Tomography (CT) uses a larger radiation dose than conventional X-rays and technological advances 
has led to more complex examinations increasing radiation doses even higher. The increased 
availability of CT machines has also facilitated the increased usage. This means that the population as 
a whole receives an increasing radiation dose and CT is now the most important contributor to 
radiation dose from medical examinations. The potential damage from ionizing radiation concerns 
long-term risks and includes cancer but other effects are known and includes cognitive difficulties 
amongst children. 
In study I we investigated the relationship between pelvimetry and negative effects from ionizing 
radiation on cognitive function expressed as changes in school grades. We examined 1 536 children 
exposed to pelvimetry in utero and compared them to 44 530 unexposed children. We found no 
negative effect on school grades when controlling for sex, birth order, mother’s education and birth 
position.  
In study II and III we examined the risk of ionizing radiation from CT of the head. We gathered data 
from a radiological archive in Sweden and collected 26 370 patients. Patients were then matched on 
age, sex and residence to 4 controls, both cohorts were then linked to national registries in order to 
gather outcome data. The outcome in study II was meningioma and in study III glioma. We found no 
evidence of increased risk for neither meningioma nor glioma after CT examinations. However, 
information in national registries were not enough for exclusion of prevalent tumor at time of first CT 
or radiotherapy, referral notes were necessary in order to minimize bias. 
Study IV is a method article and is a description of the international EPI-CT study that aims to 
investigate children who have had a CT examination. As part of EPI-CT we have collected RIS and 
PACS data from hospitals in order to assemble the Swedish cohort. This data will then be linked to 
national registries in order to investigate adverse effects from CT examinations. 
In conclusion we have not found any negative result on school performance after pelvimetry nor have 
we found any increased risk for meningioma or glial tumors after CT examination of the head.  
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1 INTRODUCTION 
As a radiologist on call, the question “How dangerous is this examination?” may be a dreaded 
one to get from a patient during lonely nights. The answer to the question is complex and 
depends not only on the nature of the examination, but also on the patient, the patient’s 
illness, as well as his or her understanding and perception of risks. An often used short and 
easy answer is that a single Computed Tomography (CT) scan is not very dangerous and that 
one can compare it to the risk from the increase in background radiation received from a 
flight over the Atlantic Ocean. Another way to answer the question is to put the examination 
in context with the risks from the disease under investigation. A more thorough discussion 
about what we know of the risks associated with radiation from diagnostic X-rays would have 
to bring up the atomic bombs over Hiroshima and Nagasaki – bad topics of discussion for any 
radiologist who wants to comfort his patients before an examination. The aim with the 
present thesis is to add new insight into risks conveyed though radiation from diagnostic 
radiology, and, hopefully, to make it more easy to give relevant advice to patients and 
referring doctors when deciding about x-ray examinations. 
 
 1 
1 INTRODUCTION 
As a radiologist on call, the question “How dangerous is this examination?” may be a dreaded 
one to get from a patient during lonely nights. The answer to the question is complex and 
depends not only on the nature of the examination, but also on the patient, the patient’s 
illness, as well as his or her understanding and perception of risks. An often used short and 
easy answer is that a single Computed Tomography (CT) scan is not very dangerous and that 
one can compare it to the risk from the increase in background radiation received from a 
flight over the Atlantic Ocean. Another way to answer the question is to put the examination 
in context with the risks from the disease under investigation. A more thorough discussion 
about what we know of the risks associated with radiation from diagnostic X-rays would have 
to bring up the atomic bombs over Hiroshima and Nagasaki – bad topics of discussion for any 
radiologist who wants to comfort his patients before an examination. The aim with the 
present thesis is to add new insight into risks conveyed though radiation from diagnostic 
radiology, and, hopefully, to make it more easy to give relevant advice to patients and 
referring doctors when deciding about x-ray examinations. 
13
14
  3 
2 BACKGROUND 
Medical X-ray imaging is an indispensable tool in the diagnosis and management of disease, 
and its importance has grown with technological advancement in particular with the arrival of 
CT-scanners in 1973.(1) However, since CT uses substantially larger amounts of ionizing 
radiation than are conveyed with conventional X-ray imaging, concerns over radiation related 
risks have been growing.(2) There are now serious concerns about the accompanied risks of 
exposing patients to large doses of ionizing radiation in medical imaging. 
2.1.1 X-ray imaging 
 
X-rays were first discovered by Wilhelm Röntgen in November 1895.(3, 4) While striving for 
brevity in writing, Röntgen named his discovery X-rays, and in the initial article he had 
already found a use for X-rays since he had managed to take an image of the bones in the 
hand of his wife (Image 1). X-rays were quickly adapted by the medical community and used 
for imaging of the body, primarily in projection radiography or conventional X-rays which 
produced two-dimensional images. When X-rays pass through the body different amounts of 
X-rays are absorbed depending on the composition of the body part. Bones absorbs more X-
rays than softer tissues, and soft tissues absorb different amounts of radiation depending on 
fat and water content, and, finally, as in the lungs, air absorbs, very few X-rays. In 
radiography, the x-rays are captured by a 
film after having passed through the 
body. Another way of visualizing x-rays 
are with fluoroscopy. In fluoroscopy, the 
x-rays strike a fluorescent material after 
passing through the body, and the 
difference in attenuation can be 
visualized in real time on a screen.(5)
   
Shortly after the discovery of X-rays, the 
dangers of ionizing radiation became 
apparent. Initially, skin erythema and loss 
of hair were the most apparent adverse 
effects from X-ray exposure while 
increased risks of cancer became visible 
among researchers investigating the 
properties of other sources of ionizing 
radiation.(6) Relatively early, it was 
speculated that an increased mortality 
among diagnostic radiologists could be 
attributed to exposure to X-rays.(7) 
Image 1- X-ray image of Anna Bertha Röntgen’s hand 
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2.1.2 Invention of the CT scanner 
The invention of CT in 1972 was a significant milestone for the medical community, and 
today CT-examinations are one of the cornerstones of a radiological department, both in 
managing emergency as well as elective diagnostics.(8, 9) The first commercially available CT 
scanner was the EMI-scanner developed by Hounsfield which became available for sale 
1973. The EMI-scanner was limited to only examining the head and it was operated by 
positioning the patient’s head in the center of the machine with the head surrounded by a 
water-filled plastic cap. The possibility of creating images of the brain was an important 
clinical innovation, even though each rotation of the X-ray tube creating just one slice of the 
head took more than 5 minutes to complete and the computer had to spend hours post 
processing in order to create the actual images.(9) Sweden in particular was an early adopter 
with the first EMI scanner installed in October 1973 at the Department of Neuroradiology at 
Karolinska Hospital.(10)  
2.1.3 CT Technology 
When performing a CT examination, the patient lies positioned on a bed with the X-ray tube 
and the detectors rotating around the patient, thus taking scans of one slice of the body from 
multiple angles. By combining data from the scans at different angles, it is possible to 
compute the attenuation coefficient – hence the term computed – of each part of the 
investigated slice, and cross-sectional images can be created that enable physicians to look at 
organs inside the body.(11) 
CT technology was initially limited by the rotating X-ray tube and detectors being attached to 
the cables that supplied electricity. This changed in 1987 with the invention of the slip ring 
scanners which enabled continuously supplying electricity to tube and detectors, regardless of 
number of rotations. This allowed for the development of the helical, or spiral, CT 
technique.(12) In a helical CT, the patient is being moved through the CT gantry while the X-
ray tube and detectors within the gantry rotate continuously. The technique has been 
developed with an increasing number of detectors and today, CT scanners with 64 detectors 
or more are able to capture the attenuation of the entire volume scanned, and to depict it in 
isometric cubes, or voxels, of 0.6 mm in length, thus allowing for creating images not only 
along the axial (head to feet) direction but also coronal (front to back) and sagittal (right to 
left) directions. Further improvements of the CT technique include use of intravenous 
contrast material(13), stereotaxic CT(14) and use of dynamic CT scanning(15) to mention just a 
few techniques developed at the Neuroradiologic Clinic at Karolinska Hospital. 
The development of CT scanners and techniques has meant that CT examinations can be used 
to diagnose an increasing variety of diseases.(1) This translates not only into patients being 
exposed to an increasing number of examinations, but also to an increasing complexity of the 
examinations used for imaging of pathological processes. Both factors have led to increased 
radiation doses to patients from diagnostic X-rays.(2) Because of the known dangers X-rays 
pose to humans – most notably in form of an increased risk of cancer – this is a cause for 
concern. The number of CT scans performed each year have increased greatly throughout the 
world, with number of scans increasing 12-fold in the UK and more than 20-fold in the USA 
from the 1980s to 2007 and there more than 60 million scans in the USA in 2007.(16) The 
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estimated effective dose of ionizing radiation per individual in the US population increased 
from 3,6 mSv in the early 1980s to 6,2 mSv in 2006, and the majority of this increase was 
attributable to radiation from medical examinations.(17) Whereas medical radiation only 
attributed to 15% of the total radiation exposure in 1980, it had increased to nearly the half in 
2006.(17, 18) In addition CT was attributed to half of the medical exposure to the patients.(17) 
Given the current usage of CT examinations, the proportion of radiation attributable to CT 
has likely increased even further. In Sweden a report on the usage of radiological 
examinations in 2005 found CT examinations contributing to 55-60% of the total radiation 
dose to the population, even though only about 12% of the total number of all radiological 
examinations were CT examinations (650 000 examinations out of 5,4 millions).(19) The 
report concludes that the total amount of CT examinations has doubled from 1995 to 2005.  
2.2 RADIATION 
Electromagnetic radiation covers a broad spectrum of different types of radiation and it can 
both be described as waves (with frequencies and wavelengths) and as photons with different 
energy content.(20) In the lower end of the electromagnetic spectrum there are radio waves and 
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beta radiation, it is highly ionizing but does not penetrate far into tissue. Alpha particles, for 
example, can be shielded from by a sheet of paper. Positrons, being the antiparticle of 
electrons, can interact directly with electrons and when they do, they annihilate each other 
and produce two gamma rays. This is the basis for Positron Emission Tomography (PET) 
examinations. Particle radiation is rarely a concern in the clinical setting as a source of 
ionizing radiation, but need to be considered in the case of research since many studies of 
ionizing radiation may not only be dealing with electromagnetic radiation but also particle 
radiation.   
2.2.2 Electromagnetic radiation 
The difference between X-rays and gamma rays are dependent not on the energy content of 
the photons but rather their source of origin. X-rays originate when electrons are rearranged 
within an atom or when an electron strikes a target (for example when an electrical current 
goes from anode to cathode in an X-ray tube) and gamma rays are emitted from radioactive 
decay of atomic nuclei. This means that there is some overlap in frequencies and thus energy 
between X-rays and gamma rays. Both X-rays and gamma rays have photons with enough 
energy to indirectly ionize molecules and atoms. The mechanism through which photons 
ionize differs depending on its energy content. Lower energetic photons ionize through 
photoelectric absorption while higher photons interact through the Compton effect and high 
energy photons, above, 5 MeV, ionize through the so called pair production.  
The photoelectric effect occurs when a photon at energies below 100 keV ejects an electron 
from the shield of an atom and the photon is extinguished with most of its energy transferred 
to the electron as kinetic energy. The Compton effect occurs at photon energies higher than 
100 keV where, once again, a photon ejects an electron, but when the photon has enough 
energy, it may also create a new secondary “scattered” photon with the energy left after 
having ejected the electron. This scattered photon can then also interact with other atoms and 
further ionize atoms through the Compton effect until a final photon is absorbed through 
photoelectric effect. The final ionizing type of interaction is the pair-production and is not 
used in medical imaging. It occurs when a photon above 1 MeV interacts with an atomic 
nucleus creating a pair consisting of one positron and one electron. These particles can then 
further ionize nearby molecules through other interactions.(22, 23)  
  
Image 3- Photoelectric effect. Photon ejects electron from the atom and the photon is extinguished. 
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Image 4- Compton effect. Photon ejects electron from atom along with a secondary scattered photon 
  
2.3 DOSIMETRY 
There are several ways of measuring dose from ionizing radiation. The most commons are 
absorbed dose, equivalent dose and effective dose.  
2.3.1 Absorbed dose 
Absorbed dose is the amount of energy deposited by ionizing radiation into matter. The SI 
unit for absorbed dose is Gray (Gy) and 1 Gy is equal to 1 joule per kilogram. Absorbed dose 
is a physical quantity and does not take into consideration the sensitivity to radiation of 
different organs in the body. A legacy unit occasionally used is rad (rad), 1 rad is equal to 
0.01 Gy. 
2.3.2 Equivalent dose 
In order to account of the different degrees to which radiation can ionize molecules, 
equivalent dose is used. Equivalent dose is calculated by multiplying the absorbed dose by a 
radiation weighting factor (WR) that depends on the type of ionizing radiation. In the case of 
X-rays, gamma and beta radiation the radiation weighting factor is 1. For particle radiation 
the WR is higher with alpha particles at 20, protons at 2 and neutrons at different values 
depending on the kinetic energy of the neutron.(24) For equivalent dose, the unit of measure is 
Sievert (Sv). An older non-SI unit is “roentgen equivalent of man” (rem) with 1 rem equal to 
0.01 Sv. 
2.3.3 Effective dose 
Effective dose is a measurement of the stochastic risk of cancer and genetic effects from 
radiation. It is calculated by taking the equivalent dose (which takes different types of 
radiation into account) and multiplying this with an organ weighting factor. To calculate the 
effective dose for one radiation event like a CT examination, the effective doses for all 
exposed organs separate are summed into one estimate. Unfortunately, effective dose uses the 
same unit of measure as absorbed dose, Sv, adding extra confusion to the field of dosimetry. 
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The effective dose is greatly dependent on the organ weighting factor. The organ weighting 
factor is calculated by taking into account studies of adverse effects of radiation. Since the 
International Commission on Radiological Protection (ICRP) first started using effective dose 
in 1977,(25) the organ weighting factors have been updated, both by several organs initially 
not included in the list having been added and organ weighting factors being revised as new 
studies are incorporated into the calculations. The most radiosensitive organs are considered 
to be colon, lung and red bone marrow.(24) 
2.4 BIOLOGICAL EFFECTS FROM IONIZING RADIATION 
The biological effects from ionizing radiation can be divided into two groups, deterministic 
and stochastic. The deterministic effects have a direct effect and a threshold dose that needs 
to be exceeded for the damage to occur. Acute radiation sickness is deterministic and occurs 
at whole body radiation at more than 1 Gy. There are less severe deterministic effects like 
hair loss and skin erythema that can occur at lower doses, and although there are a few 
reported such incidents that have occurred in radiology departments today, these were more 
common early in the 1900s.(6)  
When considering the risk of exposing a patient to a medical examination, it is most often the 
stochastic risks that are a concern. There is no threshold for stochastic effects and the effects 
are induction of cancer or other genetic effects. It is important to consider that even though 
the risk increases with dose, the severity of the effect does not, since a cancer either develops 
or it does not. 
The damage from ionizing radiation can be caused through direct interaction with molecules 
in the cell, proteins, or DNA, but the most likely pathway of damage is through radiolysis 
where free radicals are created from water molecules (H2O).(23) Water is the major component 
of cells (~80%), thus, a photon is more likely to hit a water molecule than anything else when 
traversing through tissue.(26) When a photon from an X-ray strikes a water molecule, it can 
create a multitude of various free radicals that are highly reactive and that cause negative 
effects when interacting with other nearby molecules in the cells. The higher the energy of 
the photon, the more free radicals are created. The damage to the cells is greatly dependent on 
where in the cell the free radicals are created.(27) If the photon traverse the nucleus of the cell, 
there is a possibility that changes occur in the DNA. Damage to DNA may take the form of 
either a damaged base, or single (SSB) or double (DSB) strand breaks as well as several of 
these together.(28) The cell have mechanisms to repair DNA damage, but these repair 
mechanisms are more efficient at repairing the damage in the case of base damage or a SSB, 
since in both these cases they have the second DNA strand as template when repairing. Cells 
also have different sensitivity to mutations depending on the phase of the cell cycle, with 
mitosis being the most sensitive. This is partly dependent on the amount of DNA accessible 
for interaction with ionizing radiation and partly dependent on the efficiency of the repair 
mechanisms during the cell cycle.(29) 
Oxidative stress with the creation of free radicals is a normal occurrence in a cell, and it is 
usually associated with only minimal damage. When the free radicals are created from 
ionizing radiation, however, the pattern is slightly different. Free radicals created from 
ionizing radiation tend to be clustered with a lot of free radicals occurring tightly together.(23) 
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When this happens close to DNA, the damage may be much more severe compared to the 
same amount of free radicals created from other processes. 
Histones are a group of proteins that package the DNA in the cell, when a DSB occurs in the 
DNA, the histone protein H2AX is phosphorylated and called γ-H2AX.(30) The effects of 
DNA damage after irradiation by CT examinations can be seen in an increase of γ-H2AX 
foci.(31) The formation of γ-H2AX foci makes it possible to assess DNA damage as well as 
their repair as the foci disappears. Furthermore it seems that the use of intravenous contrast 
media could further magnify the damage from ionizing radiation.(32) 
2.4.1 Cancer 
Cancer is considered a stochastic effect of radiation and it is the most dangerous somatic 
effect after exposure to doses below 1 Gy. Most of the data on cancer risks after radiation 
exposure is, however, gathered from studies of radiation doses above 100 mGy.(17, 24, 33) For 
lower doses, below 100 mGy, estimates are insecure.(34, 35) Carcinogenesis is a multistep 
process that can generally be divided into 4 steps, tumor initiation, tumor promotion, 
malignant conversion and tumor progression.(36) The changes necessary for cancer initiation 
usually occurs in just a few groups of regulatory genes that govern specific functions in the 
cell. That means that even though ionizing radiation may affect DNA, unless damage occurs 
in these specific groups of genes, cancer is unlikely to be initiated. An explanatory concept of 
these groups of genes is to divide them into gatekeeper and caretaker genes.(37) Gatekeeper 
genes can be said to protect the cell from cancer and if these genes are inactivated or their 
function removed in other ways, this often removes the normal function of cell growth. This, 
in turn, can increase the growth rate of the cell and thus increase the times DNA is copied, 
potentially increasing the risk of further errors in the DNA code. The caretaker group of 
genes deal with safeguarding the integrity of the genome such as repairing DNA, segregating 
the chromosomes properly, controlling the cell cycle and initiating apoptosis. 
2.4.2 Cognition 
Radiation has the potential to damage cells causing other adverse effects than cancer. The 
damage to the cell may cause impairment of function rather than unlimited growth or 
deterministic effects. If the cell DNA is damaged in such a way that some of its function is 
impaired this may have effects on the function of entire the organ. This concern is more 
important when considering growing cells since any DNA damage may be passed on to 
clones of the original cell and the damage to the organ may not be apparent until much later. 
Children are considered to be particularly vulnerable to this types of damages, and the 
sensitivity to radiation increases with lower age.(35)  
2.4.3 Linear No-Threshold model 
The linear no-threshold model (LNT) is a model used in radiation protection for modeling 
risks from ionizing radiation. The idea became wide-spread in the 1950s and it has since been 
the basis for thinking of radiation risk. LNT states that the risk for cancer from low dose 
radiation decreases linearly with the radiation dose. Furthermore, there is no threshold where 
the ionizing radiation does not pose any risk at all. The model is robust at higher doses above 
1 Gy and even down to lower doses to about 100 mGy. At doses below 100 mGy, there is, 
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however, some debate. The model is still considered the most likely to correctly describe the 
dose-risk association, but due to the large studies needed to assess the risk after exposure to 
small doses of radiation, the data is more uncertain, and other possible models have been 
suggested.(38, 39) Alternative models of the dose risk association below 100 mGy include that 
risks could be disproportionally higher than the same risk increase at higher doses, supra-
linearity. Alternatively, there could be biological mechanisms that are more effective at 
protecting the organism from radiation at lower doses, thus making risk lower than expected 
from the LNT model, linear-quadratic model. There is also the possibility that there could be 
a dose threshold below which there is no cancer risk at all. It has even been suggested that a 
low dose of radiation could trigger biological responses that are so beneficial that the 
radiation exposure leads not to an increase but to a decrease in the risk of cancer (also known 
as hormesis).(40)  
A consequence of LNT as current model for risk from ionizing radiation is the concept of “As 
Low As Reasonable Achievable” (ALARA) in medical imaging, meaning that the goal is to 
use as little radiation as possible to still achieve diagnostic images.  
 
Image 5- Different assumptions on the extrapolation of the cancer risk vs. radiation dose to low-dose levels, given 
a known risk at a high dose: (A) supra-linearity, (B) linear, (C) linear-quadratic, (D) hormesis 
2.5 EPIDEMIOLOGICAL STUDIES 
Studies of the risk from ionizing radiation started fairly early in the 1900s when early health 
effects became apparent among radiation researchers and health personnel. Most of the early 
health effects were different types of deterministic effects, predominantly skin erythema and 
hair loss, but more severe damages were also reported.(6) The carcinogenic effects of ionizing 
radiation among radiation workers also became apparent rather early.(7) The knowledge of the 
risks of ionizing radiation increased after the second world war with a large number of animal 
studies(41) as well as studies appearing from the LSS cohort of the atomic bomb survivors in 
Hiroshima and Nagasaki.(42, 43) Although experimental studies have been performed on 
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animals and human cells, most of the studies on human individuals have been 
epidemiological studies on exposure related to medical exposure, work or accidental 
exposure (atomic bombs or nuclear accidents). Medical exposure studies can be divided into 
either exposure from radiotherapy or from diagnostic imaging, where radiotherapy uses 
higher doses than diagnostic imaging. Recently, there have been a few studies where cancer 
risks after exposure to radiation from CT examination has been assessed through various 
patient registries.(44-46) 
2.5.1 Life Span Study 
The Life Span Study (LSS) of the Japanese Atomic Bomb survivor cohort (34, 47-49) still 
remains the largest contributor to our understanding of the risk of ionizing radiation to 
humans.  
Hiroshima was attacked by atomic bombs on August 6 and Nagasaki on August 9, 1945. In 
the immediate attack approximately 300 000 persons died, and the survivors received 
ionizing radiation in the form of gamma rays and neutrons. Shortly thereafter, in November 
26, 1946, the ABCC (Atomic Bomb Casualty Commission) was established by President 
Truman in order to study the effect of radiation on the survivors of the atomic bombs. The 
ABCC was later reorganized into the RERF (Radiation Effects Research Foundation) in 
1975. The initial of these investigative bodies were primarily focused on direct radiation 
damages as well as potential genetic effects from the radiation on the survivors and their 
descendants. It was also evident that it was possible to study cancer and mortality effects 
from the radiation exposure. Therefore, the LSS was established in 1950 with about 120 000 
survivors. There were other cohorts established as well, notably the “in utero” cohort of 3 600 
subjects, as well as the children cohort of 77 000 individuals, with overlap between the 
cohorts. The LSS cohort has multiple strengths. Apart from its large size, it contains 
individuals of both sexes as well as from all age groups. The population was also basically 
healthy at time of inclusion, and it was not selected based on any risk factors for cancer. 
Furthermore, the dosimetry of the cohort is extensive and has been updated several times with 
further improvements. Thus, the cohort exhibits a large variety of doses. Follow-up is 
virtually complete with regard to mortality, and it has very good coverage for cancer 
incidence. Finally, it has more than 60 years of follow-up time. Data on cancer are gathered 
by the cancer registries in Hiroshima and Nagasaki and includes data on non-fatal cancers as 
well as some benign tumors, and it contains histology data on the tumors. There are some 
limitations of the cohort, though, since data wasn’t collected for leukemia before 1950 and 
for solid cancers before 1958. Cancer data is also limited to residents of the Hiroshima and 
Nagasaki areas, and thus lacking information on cancer on those who moved out of the 
catchment area.(47) 
The primary endpoint from the LSS cohort has been mortality and cancer incidence, but some 
other health effects have also been studied. A subset of the LSS cohort known as the Adult 
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ionizing radiation on both specific diseases as well as organs.(50, 51) Children in utero as well 
as children born to atomic survivors have been studied for both mental and physical 
development, and genetic studies have been performed on children conceived after the atomic 
bomb explosion.(52-55) 
 
 11 
animals and human cells, most of the studies on human individuals have been 
epidemiological studies on exposure related to medical exposure, work or accidental 
exposure (atomic bombs or nuclear accidents). Medical exposure studies can be divided into 
either exposure from radiotherapy or from diagnostic imaging, where radiotherapy uses 
higher doses than diagnostic imaging. Recently, there have been a few studies where cancer 
risks after exposure to radiation from CT examination has been assessed through various 
patient registries.(44-46) 
2.5.1 Life Span Study 
The Life Span Study (LSS) of the Japanese Atomic Bomb survivor cohort (34, 47-49) still 
remains the largest contributor to our understanding of the risk of ionizing radiation to 
humans.  
Hiroshima was attacked by atomic bombs on August 6 and Nagasaki on August 9, 1945. In 
the immediate attack approximately 300 000 persons died, and the survivors received 
ionizing radiation in the form of gamma rays and neutrons. Shortly thereafter, in November 
26, 1946, the ABCC (Atomic Bomb Casualty Commission) was established by President 
Truman in order to study the effect of radiation on the survivors of the atomic bombs. The 
ABCC was later reorganized into the RERF (Radiation Effects Research Foundation) in 
1975. The initial of these investigative bodies were primarily focused on direct radiation 
damages as well as potential genetic effects from the radiation on the survivors and their 
descendants. It was also evident that it was possible to study cancer and mortality effects 
from the radiation exposure. Therefore, the LSS was established in 1950 with about 120 000 
survivors. There were other cohorts established as well, notably the “in utero” cohort of 3 600 
subjects, as well as the children cohort of 77 000 individuals, with overlap between the 
cohorts. The LSS cohort has multiple strengths. Apart from its large size, it contains 
individuals of both sexes as well as from all age groups. The population was also basically 
healthy at time of inclusion, and it was not selected based on any risk factors for cancer. 
Furthermore, the dosimetry of the cohort is extensive and has been updated several times with 
further improvements. Thus, the cohort exhibits a large variety of doses. Follow-up is 
virtually complete with regard to mortality, and it has very good coverage for cancer 
incidence. Finally, it has more than 60 years of follow-up time. Data on cancer are gathered 
by the cancer registries in Hiroshima and Nagasaki and includes data on non-fatal cancers as 
well as some benign tumors, and it contains histology data on the tumors. There are some 
limitations of the cohort, though, since data wasn’t collected for leukemia before 1950 and 
for solid cancers before 1958. Cancer data is also limited to residents of the Hiroshima and 
Nagasaki areas, and thus lacking information on cancer on those who moved out of the 
catchment area.(47) 
The primary endpoint from the LSS cohort has been mortality and cancer incidence, but some 
other health effects have also been studied. A subset of the LSS cohort known as the Adult 
Health Study (AHS) comprising 22 000 subjects have been used to evaluate the effects of 
ionizing radiation on both specific diseases as well as organs.(50, 51) Children in utero as well 
as children born to atomic survivors have been studied for both mental and physical 
development, and genetic studies have been performed on children conceived after the atomic 
bomb explosion.(52-55) 
23
 12 
There have been numerous studies and updates on the cohort since the first reports.(56) 
Dosimetry was first attempted in the T65D dosimetry(57) and was then updated, first in 1986, 
DS86(58, 59) and again in 2002, DS02.(60) Dosimetry has taken into account the location of 
each individual at the time of the atomic bomb explosions as well as possible shielding of the 
person in or outside of buildings, and on which direction the person was facing. Dosimetry 
has also taken into account that both neutron and gamma rays were produced from the atomic 
bombs. Other updates regarding mortality and cancer on the surviving members of the cohort 
has also produced new articles with the latest reports regarding the time periods 1958-
2009.(48) 
2.5.2 Medical Radiation Treatment and Diagnostics 
Radiation has been used in diagnostics but also as treatment for several diseases. In both 
cases there have been efforts to gather these patients into cohorts for studies. Radiotherapy is 
used both to treat malignant as well as benign diseases. Treatment can often be substantial, 
40-60 Gy to the region of interest but surrounding tissues receives lower doses and parts of 
the body can receive much lower doses, in the region of 100 mGy. There are some 
differences from the atomic bomb survivors in that patients may have been ill and the disease 
may not be completely unrelated to the outcome studied. Patients subjected to radiotherapy 
because of a malignant disease may also have a different sensitivity to radiation than healthy 
controls and the heterogeneous application of radiation exposure compared to uniform whole 
body exposure may make comparisons difficult. Some treatments used external radiation 
beams, but other types of radiation, such as radioactive implant have also been used. 
Patients with several different malign diseases that used radiotherapy for treatment have been 
gathered into large cohorts. Cohorts are based on treatment for uterine cervix cancer,(61-65) 
uterine corpus,(64) Hodgkin’s disease,(66-71) breast cancer survivors,(72) thyroid cancer,(73, 74). 
There are also several studies on childhood cancer survivors.(75-77) 
In addition to studies of radiotherapy there have also been several cohort studies of patients 
that have received radiotherapy for benign diseases. These include uterine bleeding,(78-80) 
ankylosing spondylitis,(81, 82) treatment for pain in joints,(83) thyrotoxicosis therapy.(84-86) There 
have also been cohorts gathered from children who have been treated for benign diseases 
with radiotherapy. Radiation was used in treatment for tinea capitis in several countries 
during the 1900s and follow-up studies on cohorts exists in both Israel and USA.(87-92) There 
are also large cohorts of patients in Sweden and France that were treated with radiation for 
skin hemangioma.(93, 94)  
In addition to studies where patients were treated for diseases there are also some studies 
where the subjects’ exposure was diagnostic examinations. There are several cohorts of 
patients with tuberculosis that had frequent fluoroscopy examinations.(95-98) There are a few 
case-control studies in USA and Sweden with diagnostic examination as exposure.(99-102) In 
Sweden there is also several cohorts that were exposed to 131I for diagnostic purposes that 
have been studied as well.(103-106)  
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There are also a few studies on children having received diagnostic examinations. One is a 
cohort of children with scoliosis evaluated for breast cancer.(107) The Oxfords Survey of 
Childhood Cancer (OSCC) is a case-control study begun in 1955 examining the radiation 
exposure among children with cancer and included prenatal exposure.(108-112) A cohort in 
USA was also investigated for prenatal exposure.(113) In Sweden a case-control study 
concerning brain tumors did not find any association.(114) In a Swedish study of patients after 
diagnostic 131I exposure also contained a small number of children.(106) 
2.5.3 Occupational Exposure to Radiation 
There is a number of studies on workers with exposure to ionizing radiation and some of the 
earliest studies on risks of ionizing radiation was of radiation workers.(7, 115) They all suffer 
from similar problems when comparing them to the type of exposure produced by medical 
diagnostic examinations. The type of ionizing radiation can vary greatly, with both particle 
and electromagnetic radiation. Usually the exposure is protracted and low-level, very 
different compared to exposure in diagnostic imaging. However the studies can be large, 
workers have been employed in nuclear industries since the 1940s and by law their doses 
must be measured. There are several national cohorts that have been combined into larger 
cohorts, including INWORKS showing slight risk increases in leukemia and solid tumors.(116-
120) Another large cohort is the workers at the Mayak plutonium facility near the Techa river 
that caused mayor radioactive contamination.(121) The workers of the Mayak facility has been 
studied numerous times with radiation exposure often high, mean doses near 1 Gy.(122) Both 
adults as well as children exposed in utero has been studied.(123-130) Airline crews are exposed 
to cosmic radiation and could potentially develop adverse effects, even though the cumulative 
dose over 20-30 years is unlikely to be larger than 200 mGy.(131, 132) Radiologists as well as 
radiological technologists have been studied as well, although initial studies showed some 
risk increase this seems to have decreased in later studies.(7, 133-136) 
2.5.4 Radiation exposure from environment 
Radiation exposure from the environment is an additional source to the population. Many 
studies have considered if nuclear facilities have an effect on the nearby population but 
contamination from nuclear facilities and atomic bomb tests have also been examined.(137-141) 
The Chernobyl nuclear plant explosion in 1986 and the resulting fallout in many countries, 
particular in the Nordic countries led to follow-up studies in many countries.(142-144) 
Background radiation can vary between regions for several reasons and there are a few 
studies on areas with a high background radiation.(145-147) Studies on this type of exposure are 
generally more interesting from a perspective of radiation protection of the population rather 
than from a medical examination standpoint. Individual doses are rarely possible to measure 
and in many cases migration as well as other risk factors are often difficult to account for.  
2.5.5 Register based studies on Computed Tomography 
Since CT was first established in 1973, it is possible to study patients examined with for 
potential health hazards with almost 50 years of follow-up. Recently three large 
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retrospectively cohorts have been established. A large cohort of about 200 000 patients under 
age of 22 in United Kingdom was examined for health risks after CT examinations and 
calculated received dose to red bone marrow and brain.(44, 148, 149) The risk of leukemia was 
positively correlated with radiation dose to the red bone marrow and similarly was risk of 
brain cancer correlated with dose to the brain. In addition relative risk was calculated 
comparing those receiving less than 5 mGy to other dose categories. For example the relative 
risk of leukemia was found to be 3.18 (95% CI 1.46 to 6.94) for those receiving at least 30 
mGy or less than 5 mGy and relative risk of brain tumors 3.32 (95% CI 1.84 to 6.42) when 
comparing the group at least 50 mGy to those with less than 5 mGy. A second study of 
almost 11 million people in Australia identified those exposed to a CT examination. They 
then compared the 680 000 exposed patients to the other 10 million unexposed patients and 
found an overall cancer incidence risk ratio of 1.24 (95% CI 1.20 to 1.29) for the exposed 
patients. There are some concerns over reverse causality, of particular concern was that the 
risk of most cancers increased except for breast cancer and leukemia, malignancies known to 
be sensitive to ionizing radiation.(45) Finally the third CT linkage study is from Taiwan 
examining 24 000 children who underwent CT of the head and for risk of subsequent brain 
tumors.(46) They found a significant increase of benign brain tumors Hazard Ratio (HR) 2.97 
(95% CI 1.49 to 5.93) between the exposed cohort and a matched unexposed cohort. Oddly 
enough, the risk was highest shortly after a 2 year latency period after the initial CT, and the 
risk for benign brain tumors then decreased. This could indicate reverse causality. Two 
smaller cohorts have been published from France and Germany and both cohorts form part of 
the EPI-CT cohort.(150, 151) Both studies are fairly small and with short follow-up time. 
Although both studies found a slight positive correlation between CT and leukemia and CNS 
tumors the result were not significant with broad confidence intervals. 
2.6 ADVERSE HEALTH EFFECTS FROM RADIATION 
2.6.1 Cancer and Mortality 
The latest report from the LSS-cohort is the third report of cancer incidence in the cohort, and 
it considers both overall cancer risk from ionizing radiation as well as site specific cancer 
risk.(48) The total follow-up period for the cohort is 52 years (although 64 years after the 
atomic bomb explosions). As the cohort is growing older, only 36% of the initial cohort is 
still alive. For the latest report, even though it is only 11 more years of follow-up after the 
previous report, the new cancers diagnosed in this time period account for 26% of the total 
amount of cancers diagnosed in the group (22 538 solid cancers).(35) The most common 
cancer was stomach cancer and other common sites were cancers of liver, breast, lung and 
colon. 
Overall, for all cancers and for both sexes the excess relative risk (ERR) per Gy of absorbed 
ionizing radiation was 0.50 (95% CI 0.42 to 0.59). Taking into account age at exposure 
shows decreasing risk with 19% for each decade older the subjects were at the time of 
exposure. For CNS tumors non-significant increases were found for both meningioma at 0.64 
ERR/Sv (95% CI: -0.01 to 1.8) and glioma 0.56 ERR/Sv (95% CI -0.2 to 2.0).(35) 
Irradiation for tinea capitis was common in the early 1900s, these patients have been followed 
for later adverse effects. A large cohort in Israel of 20 000 patients has been followed over a 
long period of time showing significant increases for both meningioma ERR/Gy of 4.63 
 
14 
retrospectively cohorts have been established. A large cohort of about 200 000 patients under 
age of 22 in United Kingdom was examined for health risks after CT examinations and 
calculated received dose to red bone marrow and brain.(44, 148, 149) The risk of leukemia was 
positively correlated with radiation dose to the red bone marrow and similarly was risk of 
brain cancer correlated with dose to the brain. In addition relative risk was calculated 
comparing those receiving less than 5 mGy to other dose categories. For example the relative 
risk of leukemia was found to be 3.18 (95% CI 1.46 to 6.94) for those receiving at least 30 
mGy or less than 5 mGy and relative risk of brain tumors 3.32 (95% CI 1.84 to 6.42) when 
comparing the group at least 50 mGy to those with less than 5 mGy. A second study of 
almost 11 million people in Australia identified those exposed to a CT examination. They 
then compared the 680 000 exposed patients to the other 10 million unexposed patients and 
found an overall cancer incidence risk ratio of 1.24 (95% CI 1.20 to 1.29) for the exposed 
patients. There are some concerns over reverse causality, of particular concern was that the 
risk of most cancers increased except for breast cancer and leukemia, malignancies known to 
be sensitive to ionizing radiation.(45) Finally the third CT linkage study is from Taiwan 
examining 24 000 children who underwent CT of the head and for risk of subsequent brain 
tumors.(46) They found a significant increase of benign brain tumors Hazard Ratio (HR) 2.97 
(95% CI 1.49 to 5.93) between the exposed cohort and a matched unexposed cohort. Oddly 
enough, the risk was highest shortly after a 2 year latency period after the initial CT, and the 
risk for benign brain tumors then decreased. This could indicate reverse causality. Two 
smaller cohorts have been published from France and Germany and both cohorts form part of 
the EPI-CT cohort.(150, 151) Both studies are fairly small and with short follow-up time. 
Although both studies found a slight positive correlation between CT and leukemia and CNS 
tumors the result were not significant with broad confidence intervals. 
2.6 ADVERSE HEALTH EFFECTS FROM RADIATION 
2.6.1 Cancer and Mortality 
The latest report from the LSS-cohort is the third report of cancer incidence in the cohort, and 
it considers both overall cancer risk from ionizing radiation as well as site specific cancer 
risk.(48) The total follow-up period for the cohort is 52 years (although 64 years after the 
atomic bomb explosions). As the cohort is growing older, only 36% of the initial cohort is 
still alive. For the latest report, even though it is only 11 more years of follow-up after the 
previous report, the new cancers diagnosed in this time period account for 26% of the total 
amount of cancers diagnosed in the group (22 538 solid cancers).(35) The most common 
cancer was stomach cancer and other common sites were cancers of liver, breast, lung and 
colon. 
Overall, for all cancers and for both sexes the excess relative risk (ERR) per Gy of absorbed 
ionizing radiation was 0.50 (95% CI 0.42 to 0.59). Taking into account age at exposure 
shows decreasing risk with 19% for each decade older the subjects were at the time of 
exposure. For CNS tumors non-significant increases were found for both meningioma at 0.64 
ERR/Sv (95% CI: -0.01 to 1.8) and glioma 0.56 ERR/Sv (95% CI -0.2 to 2.0).(35) 
Irradiation for tinea capitis was common in the early 1900s, these patients have been followed 
for later adverse effects. A large cohort in Israel of 20 000 patients has been followed over a 
long period of time showing significant increases for both meningioma ERR/Gy of 4.63 
26
  15 
(95% CI 2.43-9.12) and malign brain tumors ERR/Gy 1.98 (95% CI 0.73-4.69).(87, 89) The 
patients received high doses, in the range of 1 to 6 Gy. A Swedish study of two cohorts 
treated with radiation for skin hemangioma, received lower doses, with mean dose of 700 
mGy also found increases in brain tumors with ERR/Gy of 2.7 (95% CI 1.0 to 5.6) for the 
whole population.(152) 
 
Image 6- Excess relative risk of solid cancer from radiation dose for Atomic bomb survivors(153) 
2.6.2 Leukemia 
An increased risk of leukemia amongst radiologist was reported as early as 1944.(7) Studies 
on the survivors of atomic bomb explosions of Hiroshima and Nagasaki further strengthened 
this finding as the studies progressed.(42, 154, 155) The LSS studies on leukemia have shown that 
younger individuals are more sensitive and that most of the leukemia cases appear early after 
the exposure, peaking after 6 to 8 years, and then taper off to a slight persistent risk increase 
even after 50 years of follow-up.(154) The overall risk for all leukemia other than chronic 
lymphatic leukemia (CLL) and Acute T-cell leukemia (ATL) (neither seems strongly 
correlated with radiation(154)) is about  4.66 (95% CI 4.07 to 6.88) at 1 Sv and depending on 
age at and time since exposure. One effect of this is that the risk is three times higher at 1 Sv 
than 0.1 Sv.(44, 156) Furthermore the effect of radiation seems to be most pronounced in certain 
types of leukemia notably acute lymphatic leukemia (ALL) and chronic myeloid leukemia 
(CML). Other types of leukemia show slightly less increase of. Studies of a population near 
the heavily polluted Techa River in Russia also show increased risk of leukemia with 4.9 
relative risk increase per Gy (95% CI 1.6 to 14.3).(123, 124) Other exposures includes 
population living near nuclear facilities(157) as well at workers at nuclear facilities without 
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finding any increased risk.(116) Studies of children exposed to medical examinations in utero 
show slight increase in relative risk but they lack statistical significance.(158, 159) There are a 
few other studies with radiation exposure and leukemia as outcome. A study on cervix cancer 
survivors with a mean dose of 7 Gy showed a slight increase in leukemia with ERR/Gy 
0.88.(61) The Israeli tinea capitis cohort has also been examined for leukemia mortality 
showing a slight increase at 2.3 (95% CI 1.0 to 5.6).(88) The Swedish patients treated for skin 
hemangioma did not show any increase in leukemia.(160) 
2.6.3 Cognition 
The risk of adverse effects of ionizing radiation exposure to the fetus was investigated as 
early as during the 1920s with studies finding the possibility of severe cognitive damage 
caused by ionizing radiation.(161) The children that were in utero at the time of the atomic 
bomb explosion were followed and during the 1950s were examined for possible cognitive 
effects. Initially this was defined as severe mental retardation,(162) being unable to perform 
simple arithmetic or form coherent sentences and manage personal affairs and or requiring 
institutionalization. Other outcomes include head size(163), IQ(164), school grades(165) as well as 
history of seizures.(166) Later, some children were examined with Magnetic Resonance 
Imaging (MRI).(167)  
Some general conclusions of these studies can be drawn:(168) there is a period where the fetus 
is more sensitive to ionizing radiation during week 8-15 of the pregnancy. Most of the cases 
of mental retardation were found to have been irradiated during this period. To a lesser extent 
children, exposed in utero in gestational age 16-25 weeks also showed a sensitivity to 
radiation. The risks from ionizing radiation increased with increasing dose and they were 
statistically significant for all studies at radiation doses above 500 mGy. A negative effect on 
both school performance and IQ was shown for lower doses, however, for doses below 100 
mGy the bounds of the confidence intervals were broader and not statistically significant. 
Furthermore, there was a suggestion of a threshold at 0.55 Gy (95% CI 0.31 to 9.61) for the 
most sensitive group exposed between 8-15 weeks.(169) For school performance and IQ, no 
such threshold was found although both these studies contain fewer subjects.(164, 165) Cell 
death is a possible mechanism for these effects but MRI examinations indicate that another 
possible mechanism for the lower cognitive function is that the migration of neuronal cells 
mostly occur between the 12th and 24th week of gestation which is similar to the time period 
where the fetuses brain seems most vulnerable to radiation.(170)  
There have been a few other studies on prenatally irradiated children. One study on 544 
children irradiated in utero from the Chernobyl accident showed decrease of IQ compared to 
a control group.(171) A study on children living in Sweden exposed in utero to fallout radiation 
from the Chernobyl nuclear plant accident found a significant decrease in school performance 
compared to children born in areas with less radiation from nuclear fallout.(172) This finding 
suggests that neurological effects of radiation may be more subtle than what was shown in the 
In Utero cohort from Hiroshima and Nagasaki. Similarly, a study on Norwegian children 
exposed in utero to the fallout from Chernobyl also found a negative effect on IQ for those 
exposed during the sensitive week 8-15.(173)  
There are also some cohorts where the radiation exposure occurred postnatally. In one study 
from Israel there were 20 000 children treated with X-rays for tinea capitis.(174) Although 
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individual doses were not available, the estimated average dose was 1.3 Gy, the study found 
differences between the irradiated children and their controls in both school performance and 
IQ tests. The exposed cohort were less likely to complete elementary school and also had 
slightly lower score at the army IQ test-score compared to the unexposed group. In a small 
study of cognitive abilities of patients treated with radiation for leukemia showed a majority 
of patients with learning disabilities, the dose in the cohort tended to be high, 18-24 Gy.(175) A 
study on 3 094 children irradiated as infants before 18 months of age for skin hemangioma 
studied school graduation as well as psychological tests at 18 years of age.(176) Doses were 
low with an average dose of 52 mGy and found that children receiving higher doses (>100 
mGy) to the brain were about half as likely to graduate from secondary school compared to 
children whose brains did not receive any radiation. A follow-up study on other patients in 
the Swedish skin hemangioma cohorts did not find any significant cognitive negative effect 
of radiation to the head.(177) 
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3 METHODS 
Sweden uses a personal identification number (PIN) as the Swedish national identification 
number for every resident in Sweden. This PIN is used in contact with hospitals and other 
health services as well as with other governmental services. The government also uses the 
PIN when collecting health data in health registries which can be used for both statistics as 
well as made available for health research.(178) 
3.1 DATA SOURCES 
3.1.1 The National Patient Register 
The National patient registry is maintained by the Swedish National Board of Health and 
welfare and provides data on patient treatment. It started in 1964 with gradual coverage of 
parts of Sweden and since 1987 it covers all regions of Sweden for in-hospital care. 
Outpatient treatment were added in 2001. It contains data on treatment as well as hospital 
discharge codes according to the ICD-classification, and for most diseases the data have a 
high validity.(179)  
3.1.2 Swedish Cancer Register 
Swedish National Board of Health and welfare is responsible for gathering data on cancer 
incidence and survival and maintains the Swedish Cancer register since 1958 that contains 
data on diagnosed cancers for research purpose and statistics. It covers the whole of the 
population in Sweden and has a high completeness of data.(180)  
3.1.3 Total Population Register 
The total population registry was started in 1968 and today it’s maintained by Statistics 
Sweden (SCB). It contains data on residents in Sweden.(181) The register contains data on life 
events such as birth, death, emigration, immigration, marital status, as well as family 
relationships. It also registers address and migration within Sweden. 
3.1.4 Multi-Generation Register 
The Swedish Multi-generation register is maintained by Statistics Sweden and contains 
information on all individuals born in Sweden since 1932 as well as all people alive in 
Sweden 1961. The register contains data on individual’s parents as well as their children.(182). 
3.1.5 Radiological Information System 
The Radiological Information System (RIS) is a type of medical journal for radiological 
departments adjusted to their practices. It’s used for receiving requests for examinations, 
planning and scheduling examinations as well as reporting findings. In Sweden they are 
usually based on PIN, and it is therefore easy to collect data from RIS and link this 
information to other registers. Apart from PIN, important data in RIS includes type of 
examination and date of examination. The use of computerized RIS in Sweden started in the 
1980-ies with the region of Östergötland one of the first in Sweden. Gradually the rest of the 
regions were also converted to using digital RIS with the latest converting in the late 2000s.  
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3.1.6 PACS 
Picture archiving and communications system (PACS) is used in radiological departments for 
storing and viewing the images of radiological examinations.(183) The images are sent from 
radiological equipment after the examinations is performed and the RIS system is then able to 
retrieve the images for the radiologist for evaluation. PACS contains not only the images but 
also information about the examination in DICOM (Digital Imaging and Communications in 
Medicine) headers attached to each image that may include data on the radiation exposure 
used in the examination. For a CT examination information about radiation is stored in each 
slice of the original examination. Thus it is possible to retrieve data on radiation from PACS 
to reconstruct dose to the patient. (184) 
3.2 STUDY I 
Study I was a cohort study of children born in the 1980s in the region of Östergötland in 
Sweden. The cohort consisted of one group that was exposed to a pelvimetric examination in 
utero and one unexposed group. We gathered data from a RIS in Östergötland that 
encompassed all major radiological departments. The RIS was digitalized in the 1980s and 
we gathered data on radiological examinations of the abdomen on all women, but included 
only pelvimetry. All women who had a pelvimetry were then linked to the Multi-Generation 
register in order to find any children born within 9 months of that examination, as well as any 
siblings. Primary school grades were gathered for all children in Östergötland from the 
Nationella Betygsdatabasen (BEDA). Additional data on emigration, parental income and 
education levels were gathered from Total population register. Lacking individual dosimetry 
in RIS data, doses were instead estimated to be 1 to 3 mSv based on standard practices during 
the time period.(185) 
3.3 STUDY II AND III 
At the Neuroradiologic Department in the Karolinska Hospital in Stockholm they had a 
radiological archive with stored carbon copies of original referral notes for CT examinations. 
These carbon copies contained PIN as well as type and date of examination and the report 
from the radiologist, clinical history was usually available as well. Data from the archive was 
abstracted into a database where additional data on Gamma Knife treatment was added. The 
database was then prepared for linkage and Statistics Sweden selected four unexposed 
controls matched on age, sex and residency at time of first examination. Both groups were 
then linked to the Cancer Register and National Patient Register for outcome data. Outcome 
data was based on ICD-codes as well as histopathology codes in the Cancer register. ICD 
revision 7 were used with codes to identify brain tumors (193.0, 193.1 193.2, 193.8, 193.9). 
In addition histopathological codes C24 were used to identify the type of tumor. In study 2 
histopathological codes 461, 463 and 466 for meningioma was used. In study 3 
histopathological codes 475, 476, 481 and 485 was used for glial tumors. The National 
patient register was examined for possible confounding diseases: neurofibromatosis type 1 
and 2 (NF1 and NF2) and tuberous sclerosis since these diagnoses were possible 
confounders.(186) The radiological archive contained additional clinical data that was not 
abstracted into the database. For all cases in the exposed cohort the data on both referral notes 
and radiological report was also examined for history of tumor, cancer or previous radiation 
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therapy. Individual dosimetry was not possible but it was possible to identify the type of 
scanner used for the examination as well as the number of series performed. The 
Neuroradiologic department initially installed the EMI Mark I scanner and later the GE 8800 
scanner. Dosimetry was based on historical exposure data in the literature while taking the 
number of series into account.(187) 
 
Image 7- Selection of cohort in Study II 
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3.4 STUDY IV 
Study IV is an article describing the method of how the data was collected and the assembly 
of the cohorts was made, analyzes of outcome data has yet to be performed. 
EPI-CT is an international study aimed at gathering a sufficient large cohort to examine if the 
ionizing radiation used in radiological examinations causes cancer. In order to collect one 
million exposed children several countries are contributing study subjects. The majority of 
data comes from United Kingdom with a previously described cohort(44) of 320 000 patients 
and Sweden contributing more than of 100 000 patients. In addition to Sweden and the 
United Kingdom a further seven countries will provide data: Belgium, Denmark, France, 
Germany, Netherlands, Norway and Spain. The Swedish data is principally RIS-data 
collected from four major regions in Sweden; Stockholm, Göteborg, Skåne, Östergötland. 
The regions all had RIS-data collected from several hospitals and any individual examined 
with a CT examination before 18 years of age was selected and information on all 
examinations for those individuals both as children and adults was collected. Additionally 
PACS-data were collected in Stockholm for dosimetry. Outcome data was collected from the 
Cancer Register as well as the National Patient Register and some socioeconomic data was 
collected from the Total Population Register. The initial primary outcome diagnosis will be 
mortality with leukemia also studied, since previous epidemiological studies indicate this 
malignancy having the lowest incubation period. The article describes the general method 
used in order to construct the study population.  
3.5 STATISTICAL ANALYSIS 
For statistical analysis of data Study 1 used linear regression. Linear regression is used where 
there is one outcome and one or more independent variables. Simple linear regression is used 
where there is only one independent variable and multiple linear regression where there are 
multiple independent variables. The analysis were performed on STATA (v10, StataCorp, 
College Station, TX). 
The data was analyzed with final grades of primary school expressed in centiles as outcome 
variable, and pelvimetric examination during pregnancy as exposure. The statistical analysis 
was performed with linear regression with school grades as outcome variable and sex, 
pelvimetry, birth position, birth order, maternal income, and maternal education as 
independent variables. In both the simple and multiple linear regression analysis, data were 
stratified on birth year. A separate analysis restricted to the exposed children and their 
siblings was also performed. In this analysis, sex, pelvimetry, birth order, and birth position 
were used as independent variables. As in the other analyses, data was stratified on birth year 
in both the simple and multiple analysis. In cases where individuals had missing data in one 
category, they were omitted from analysis. 
In Study II and III Cox proportional hazard regression was used for the statistical analysis.(188) 
Cox proportional hazard regression is a type of survival model. Survival models follow 
subjects over time until an event of interest occurs. Cox proportional hazard regression (HR) 
models the ratio between two different hazard rates. 
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The relative risk of a CT examination were calculated with a proportional hazard model with 
meningioma or brain tumors as dependent outcome variable and CT-exposure or radiation 
dose as independent variables. In addition HR was calculated in two year intervals after the 
first CT examination. Analyses were stratified on the basis of sex, age and year of inclusion 
in the study in 5 year intervals. The analysis was performed on SAS (v9.4, SAS Institute, 
Cary, NC). 
Study IV describes the EPI-CT cohort as well as the Swedish part of the cohort in regards to 
how the data was collected and assembled. No statistical analysis on outcomes has yet been 
performed in Study IV. Analysis will be focused on dose-response between radiation 
exposure from CT examinations and mortality in both cancer and overall mortality. 
Outcomes in the study population will then be compared to Standardized Mortality Ratios 
(SMR), calculated as ratio of observed and expected number of deaths based on national 
reference levels.  
3.6 ETHICAL CONSIDERATIONS 
Although the risks of radiation in doses above 100 mGy are well established there is still 
uncertainty of the risks below this level. Since many radiological examinations have doses 
below 100 mGy there is still a need for research in this area.  
In all of the four studies performed, informed consent was waived after approval from the 
local ethics board. There are several reasons why the studies was performed without informed 
consent. All studies consists of patients and controls where the data was gathered from 
archives. In study II and III the long follow-up time combined with the fact that many 
examined patients were older as well as likely to have a serious disease. It is thus probable 
that a significant proportion of patients would be deceased, making it impossible to secure 
informed consent in the same way between alive and deceased, therefore introducing 
significant bias in those studies. In study I and IV, although most patients would likely be 
alive, since their examinations were performed in a later time period than study II and III it 
would still be difficult to collect consent without introducing bias. 
The studies use clinical data received from hospitals with personal information. The data has 
been stored and handled by a small number of people during research within closed facilities. 
The data analysis after linkage to national registries was performed on anonymized data 
where name and PIN were removed.  
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4 RESULTS 
4.1 STUDY I 
The study cohort consisted of a total of 46 066 children, with 1 536 children exposed to a 
pelvimetric examination in utero with their 1 095 siblings. In addition there were 43 435 
unexposed children. In the initial crude analysis we found that being exposed to a pelvimetry 
increased the grades by 3 points (95 % CI, 1.5 to 4.6). However with a multiple regression 
analysis including potential risk factors such as sex, birth order, the mother’s highest 
graduation level and birth position the estimate decreased. Instead we found a non-significant 
increase in grades at 1.4 (95 % CI, -0.1 to 2.8). A separate analysis was performed comparing 
only the exposed children with their siblings. Neither simple nor multiple regression analysis 
showed any significant negative effect on grades after radiation exposure. 
   Simple analysis1   Multiple analysis2   
      
point estimate 
(95 % CI)   
point estimate 
(95 % CI)   
              
  Pelvimetry          
    Yes 3.0 (1.5 to 4.6)  1.4 (-0.1 to 2.8)   
    No 0 (ref)  0 (ref)   
        
   
  Sibling Analysis   
     Simple analysis1  Multiple analysis3   
  
point estimate 
(95 % CI)  
point estimate 
(95 % CI)  
  Pelvimetry      
   Yes 1.7 (-0.5 to 3.9)  1.5 (-0.9 to 3.9)   
   No 0 (ref)  0 (ref)   
          
          
  1 All models controlled for birthyear       
  2 Model controlled for birth year, sex, pelvimetry, birth order, birth position, 
mother's education level and mother's income 
  
    
 3 Model controlled for birth year, sex, pelvimetry, birth order  
              
Table 1-Analysis of covariates and effect on percentile rank in primary school grades between children exposed 
to pelvimetric examination during pregnancy and unexposed children as well as between exposed children and 
unexposed siblings 
4.2 STUDY II AND III 
The radiological archive that forms the basis of study II and III initially contained records on 
35 095 patients. A significant portion of the patients was removed due to missing information 
of either PIN (3 952 patients, often foreign patients) or missing information on the 
examination (2 536 patients) and 28 607 patients remained before linkage to national 
registries. After linkage additional preparation of the cohorts was performed and the final 
study cohort consisted of 26 370 patients in study II and 26 315 patients in study III. In study 
III a further 55 patients were removed due to a diagnosis of tuberous sclerosis. We performed 
analyses with a 5 and a 10 year exclusion period after the initial CT examination. 
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In initial analysis in study II we found a total of 48 meningiomas cases among the exposed 
group and 64 meningiomas in the unexposed group. After analysis an increased risk for 
meningioma of 2.28 (95 % CI 1.56 to 3.33) with a 5 year exclusion period was found and 
2.33 (95 % CI 1.49 to 3.64) with a 10 year exclusion period. Analysis on dose was performed 
after dividing patients into groups of total dose of 50 mGy and after both exclusion periods 
significant risk increase of meningioma were found in groups having received more than 50 
mGy. In addition trend analysis for the groups were significant. However having access to the 
original referral notes these were examined for any additional risk factors. The referral notes 
contained information on 16 patients that had reasons for exclusions but with data not found 
earlier in national registries or in gamma knife treatment registry. Of these 16 patients 7 had a 
meningioma at first CT examination, 4 had a non-meningeal brain tumor and 5 had received 
radiotherapy to the head. Taking these data into account and excluding these additional 16 
patients decreased the risk of meningioma after CT examination. The HR after the 5 year 
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In study III we restricted our analysis to tumors originating from glial structures and found 37 
tumors in the exposed group compared to 88 in the unexposed group. After analyzing the 
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After taking clinical information into account the HR for a CT examination was 0.81 (95 % 
CI 0.51 to 1.30) after a 5 year exclusion period and HR after 10 year exclusion was 0.69 (95 
% CI 0.37 to 1.29).  
 
 25 
In initial analysis in study II we found a total of 48 meningiomas cases among the exposed 
group and 64 meningiomas in the unexposed group. After analysis an increased risk for 
meningioma of 2.28 (95 % CI 1.56 to 3.33) with a 5 year exclusion period was found and 
2.33 (95 % CI 1.49 to 3.64) with a 10 year exclusion period. Analysis on dose was performed 
after dividing patients into groups of total dose of 50 mGy and after both exclusion periods 
significant risk increase of meningioma were found in groups having received more than 50 
mGy. In addition trend analysis for the groups were significant. However having access to the 
original referral notes these were examined for any additional risk factors. The referral notes 
contained information on 16 patients that had reasons for exclusions but with data not found 
earlier in national registries or in gamma knife treatment registry. Of these 16 patients 7 had a 
meningioma at first CT examination, 4 had a non-meningeal brain tumor and 5 had received 
radiotherapy to the head. Taking these data into account and excluding these additional 16 
patients decreased the risk of meningioma after CT examination. The HR after the 5 year 
exclusion was 1.49 (95 % CI 0.97 to 2.30) and after 10 year exclusion was 1.49 (95 % CI 
0.87 to 2.48). The previously seen increased risk for different dose categories as well as trend 
analysis for dose groups also decreased and were no longer statistically significant.  
 Outcomes 5 year exclusion period 10 year exclusion period  
  Without referral 
check  
 
With referral 
check 
Without referral 
check  
With referral 
check 
 
  point estimate 
(95 % CI) 
point estimate 
(95 % CI) 
point estimate 
(95 % CI) 
point estimate 
(95 % CI) 
 
 Meningioma      
 Exposed1 2.28 
(1.56 to 3.33) 
1.49 
(0.97 to 2.30) 
2.33 
(1.49 to 3.64) 
1.49 
(0.89 to 2.48) 
 
 Non exposed 1 1 1 1  
       
 Glial Tumors      
 Exposed1 1.38 
(0.94 to 2.03) 
0.81 
(0.51 to 1.30) 
0.92 
(0.53 to 1.60) 
0.69 
(0.37 to 1.29) 
 
 Non exposed 1 1 1 1  
 1Stratified by age, sex, time-period for inclusion    
       
Table 1-HR for meningioma and glial tumors for exposed and unexposed group using either a 5 or 10 year 
exclusion period as well as with or without check of referral notes 
In study III we restricted our analysis to tumors originating from glial structures and found 37 
tumors in the exposed group compared to 88 in the unexposed group. After analyzing the 
clinical information on referral notes 15 of the 37 tumors in the exposed group were removed 
from final analysis, 14 due to presence of brain tumor at first CT and 1 due to radiotherapy. 
Initial analysis without clinical information did not find any significant increase in tumors 
after a CT examination, a significant increase in trend when considering doses was found. 
After taking clinical information into account the HR for a CT examination was 0.81 (95 % 
CI 0.51 to 1.30) after a 5 year exclusion period and HR after 10 year exclusion was 0.69 (95 
% CI 0.37 to 1.29).  
37
 26 
4.3 STUDY IV 
Study IV describes the collection of data and assembly of EPI-CT cohort. Final results on the 
EPI-CT in regards to outcome data on mortality or incidence of leukemia and solid cancers 
have yet to be performed. The projected size for the Swedish part of the EPI-CT cohort is 
95 000 patients (9.2%) out of total cohort of 1 032 000 patients. The Swedish patients were 
examined between from 1984 to 2013 and the age of patients are between 0 and 18 years.  
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5 DISCUSSION 
In our studies of the risk of adverse events after exposure to diagnostic X-rays, we found no 
effects on school grades after in utero exposure to pelvimetry, nor did we find any increase 
in risks of brain tumor or meningioma after CT exposure to the head. In addition, we found 
that in studies of risk of brain tumor and meningioma after CT exposure, information from 
radiology reports are essential in order not to overestimate the risks. 
The knowledge of the adverse effects on cognition after low dose radiation to the head is in 
large part based on cohort studies of the survivors of the atomic bombs over Hiroshima and 
Nagasaki, in particular of the in utero cohort of children exposed before birth and born after 
the explosion.(189) The cognitive abilities of the children in this cohort have been measured 
in several ways. IQ and school performance were measured when the children were 10 or 
11 years old, and the results suggest that the most sensitive time for the fetus was during 
weeks 8-15, and, to a lesser extent, during weeks 16-25. Study I included a total of 1 536 
exposed patients compared to the 1 613 children included in the in utero cohort, and 
cognition was measured as primary school grades at approximately age 15. The radiation 
exposure in our study was a pelvimetric examination which was mostly performed later in 
pregnancy, after week 25, and doses were both lower and within a more narrow range than 
was the case for the atomic bomb survivors. Although the radiation exposure in our study 
occurred late in pregnancy and therefore should, on the basis of what is known from the in 
utero cohort, have little effect on cognition, the larger cohort size and the more uniform 
dose interval still add important information. Pelvimetry may no longer be as common an 
examination as it was when our cohort was exposed in the 1980s, but there are other types 
of radiological examinations during pregnancy that exposes the fetus to radiation, and it is 
therefore reassuring that doses in the range as conveyed to the fetus from a pelvimetry can 
be considered safe with regard to school performance. 
Counterintuitively to an expected decrease in school grades after radiation exposure to the 
head, Study I found a slight increase in grades in the simple regression analysis. In the 
multiple regression analysis, however, this increase was no longer statistically significant, 
even though the point estimate was positive, and similarly, a slight increase in grades was 
found when the analysis was restricted to families with exposed children and unexposed 
siblings. It is likely that this is due to a residual bias from socio-economic factors and birth 
order. Finally, although for other fields than radiation research, it is noteworthy that some 
of the factors we controlled for strongly influenced the children’s school grades, in 
particular the mother’s education level and sex of the child.  
Study II and III examined if there were any increases in risk of brain tumor or meningioma 
after CT examinations to the head, and we found no statistically significant increases in 
risk. Risk of solid tumors increase in most organs after radiation exposure although there 
was only a slight indication of increased risk in the latest report of the LSS studies of 
relatively low doses of radiation.(34) Previous studies have indicated that meningioma is the 
most radiosensitive tumor of the head,(87) and there have been some indications of an 
increased risk of meningioma after medical examinations.(101, 190) More recent studies on 
risk after CT examinations of the head, however, have shown much larger increases in risk 
than in studies based on other exposures.(44-46) There are, however, some results in these 
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studies that differ to what is known from other radiation studies:(191) The risk of cancer 
appeared much earlier than expected, the risk of brain tumors were increased even though 
CT examinations were not of the head,(45, 46) and the risk increase was larger for older 
children than for younger.(44) There are also some indications that the risk increase may 
partly be explained by predisposing factors.(151) In both study II and III we found that 
without the information in radiology reports from the time of the first CT examination, 
patients with a history of radiation treatment to the head and prevalent tumors at time of 
examination would have been erroneously included in the study and the estimates of risks 
would have been falsely high.(192) This finding have been further studied in the CT cohort 
from United Kingdom and found that clinical information from 40% of patients did not 
affect results meaningfully.(193) The studies that found unexpectedly high risks of brain 
tumors and meningiomas after CT exposure were performed without access to the 
radiology reports, and it is likely that this may have influenced the results. Furthermore, an 
additional complication when studying the risk of meningioma as an outcome lies in the 
fact that the diagnosis of meningioma is likely to be delayed compared to most other brain 
tumors. Delayed diagnosis should be suspected since pathological diagnosis, and thus 
registration in cancer registries, of meningioma often is delayed until operation. Since 
meningiomas does not metastasize, this operation may be delayed for a long time. In Study 
II, one patient had a delay of more than 15 years from diagnosis of meningioma in the 
radiology report to registration in the cancer register. This delay in registration may, 
evidently, also skew the results.  
Although we found no overall increase in risk of meningioma after CT exposure to the 
head, there was a slight suggestion that the risk increased near the end of follow-up. This 
would be consistent with what is expected from cancer biology, and it is possible that a new 
assessment of risk of meningioma in the cohort with additional follow-up time may shed 
light of this finding. Likewise, a study with longer follow-up may reveal whether the 
nonsignificant suggestion of a stepwise increase in risk of meningioma with increasing 
radiation dose - larger than what was expected from the studies of the LSS cohorts – was a 
true finding or due to chance. Additional studies of the cohort at a later time should also be 
considered to see if, similarly to LSS studies, any increases in risk persist as subjects grow 
older.  
In study III glial tumors were examined. Since glial tumors exist in both slow growing and 
faster growing forms, it is not surprising that the results of study III were similar to study II. 
In addition, glial tumors in general have not been shown to be particularly radiosensitive. 
The decreased risk that we found should be considered in contrast to the increased risk in 
glial tumors found in the English cohort of CT exposed patient.(44) In study III we had 
knowledge of clinical status at first CT examination and could therefore exclude patients 
that were not eligible. There may still be residual reversed causation in study III if there 
were a glioma giving symptoms leading to a CT scan, and thus present at time of first CT, 
but not found in the radiology rapport. Even today, with much improved scanners compared 
to the scanners used in our study, low-grade astrocytoma may show only subtle signs on 
CT, and with older equipment they may have been even harder to identify.  
One serious limitation with both Study II and III is that exposed and unexposed cohorts 
were treated differently since the information from the radiology reports on the exposed 
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cohort was not available for the unexposed cohort. If there were other hospitals in the 
Stockholm area giving gamma knife therapy to patients that could be included in the 
control cohort of our study, or if exposure to CT of the head at other radiology departments 
was a common exposure during the study period, this would bias the results. Since this is 
not the case, however, we do not consider this being a threat to the validity of our results. 
The EPI-CT study is an attempt to further investigate the risk of radiation exposure from 
CT examinations. The study includes children, who are more radiosensitive than adults. CT 
examinations are likely the diagnostic examination with the largest amount of radiation 
dose that children are likely to be exposed to. EPI-CT will study leukemia since this is a 
disease that in the LSS cohorts has been shown to increase shortly after exposure but with a 
long-term persistent risk increase.(154) The potential bias emanating from long time periods 
between disease occurrence and diagnosis that we have found in Study II and III will 
therefore not be a problem in EPI-CT. In order to have sufficient statistical power to find an 
increase in risk of leukemia after CT exposure, a cohort of 1 million children was found to 
be necessary. Hopefully, in the EPI-CT study it will also be possible to model dose-
response curves, although obtaining accurate radiation doses for the exposed children may 
be challenging since it is possible to identify the body part that was examined, but it may be 
more difficult to identify which protocol was used. The protocol for a CT examination may 
indicate one or several series as well as different settings for the X-ray tube, leading to large 
variations in dose between different protocols. In spite of all challenges, the EPI-CT study 
will provide excellent opportunities to address the potential risks associated with diagnostic 
x-ray exposure. 
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6 CONCLUSIONS 
In conclusion, we have found that: 
• There was no indication of adverse effects on cognition measured as school grades 
after in utero exposure to pelvimetry.  
• Without information from the radiology reports, studies of the association between 
CT exposure and risk of brain tumor and meningioma may give erroneus results 
since these may be biased by patients with prevalent tumors at time of exposure or a 
history of radiation treatment to the head being included in the study.  
• In a cohort of more than 26 000 patients examined with CT and followed for up to 
21 years, there was no increase in risk of meningioma or glial tumors . 
There is still need for further research in regards to low doses of radiation, similar to what 
patients may receive after a medical examination. The EPI-CT study will hopefully be a 
useful addition to these types of studies since the study population is drawn directly from 
health care systems and bias, as experienced in study II and III, can be addressed.  
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7 KORTFATTAD VERSION PÅ SVENSKA 
Röntgenstrålningen upptäcktes 1895 och blev snabbt anammat av sjukvården. Dock 
upptäcktes snart att det fanns risker med röntgenstrålning både för patienter och för personal 
om försiktighetsåtgärder inte vidtogs. 1973 blev datortomografin (DT) tillgänglig för 
medicinen. Patienter som undersöks med DT ligger på en brits i maskinen och sedan roterar 
röntgenröret runt patienten och tar många exponeringar från flera vinklar. Dessa exponeringar 
kan sedan sättas samman till ett tvärsnitt av patienten. DT var en stor framgång och antalet 
undersökningar ökade kraftigt, dock så innebär en undersökning med datortomografi högre 
stråldoser än vid konventionell röntgen. Dessutom har den tekniska utvecklingen sedan 
upptäckten lett till att datortomografier har blivit snabbare och vanligare undersökningar, och 
starkare röntgenrör har lett till att DT kan göra mer komplexa undersökningar vilket också 
ökar stråldosen för undersökningen. De ökade stråldoserna från DT har lett till att den 
genomsnittliga strålningen till populationen har ökat. Det finns nu en ökande oro för att 
ökningen av strålning från DT kan leda till negativa effekter på hälsan hos befolkningen.  
Röntgenstrålning kan skada cellernas DNA, båda bryta sönder DNA-kedjan men även orsaka 
mutationer. Upprepade mutationer i cellernas DNA kan över en lång tid ge upphov till 
cancer.  
Tidigare studier på riskerna med röntgenstrålning har visat en ökad risk för både leukemi och 
solida cancrar, men röntgenstrålning på barn har även visats kunna ge skador på hjärnan som 
lett till nedsatt intelligens. En stor del av kunskapen om riskerna med strålning i de doser som 
förekommer vid datortomografi kommer från studier på atombombsöverlevarna från 
Hiroshima och Nagasaki. Andra studier som har genomförts har bland annat undersökt 
patienter som fått strålning från diagnostiska undersökningar och strålterapi. Det finns också 
studier som undersökt individer som exponerats för strålning i samband med yrkesutövning 
eller som utsatts för strålning från föroreningar eller från levt i områden med ökad strålning. 
Kunskapen från studier om röntgenstrålning har tydligt visat att höga doser, över 100 mGy 
kan ge cancer. De flesta röntgenundersökningar har dock mycket lägre stråldoser och även 
om det finns flera studier som visar på en ökad risk för cancer i dessa nivåer finns det en 
större osäkerhet. Idag anses varje röntgenundersökning kunna utgöra en risk för att orsaka 
cancer men det finns en osäkerhet i hur stor den risken är vilket gör det svårt att ställa den 
mot nyttan med en undersökning. 
I vår första studie har vi undersökt 1 500 barn som på 80-talet var exponerade för 
röntgenstrålning in utero när deras mamma gjorde en bäckenmätning under graviditeten. 
Dessa barn har sedan jämförts med icke-exponerade barn, inklusive deras syskon avseende 
barnens skolbetyg i högstadiet. Vi kunde inte se några negativa effekter på skolbetyg av 
strålning från en bäckenmätning. 
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röntgenstrålning in utero när deras mamma gjorde en bäckenmätning under graviditeten. 
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I studie II och III hade vi samlat patientdata från ett arkiv med röntgenremisser i pappersform. 
I arkivet fanns data om 26 000 patienter med namn, personnummer och vilken undersökning 
som gjorts. Efter att ha matchat patienterna med 4 ggr så många oexponerade individer 
länkades alla till nationella register som Cancerregistret för att undersöka om det fanns ett 
samband mellan DT undersökningen och meningiom eller gliala tumörer. Vi fann ingen ökad 
risk för varken meningiom eller gliala tumörer efter att ha gjort DT-undersökningar. Vi fann 
dock att det var nödvändigt att ha tillgång till röntgenremisserna för att korrekt kunna 
exkludera patienter som hade en tumör redan vid första undersökningen. Utan informationen 
från remisserna hade vi hittat ett falsk förhöjt samband. 
Studie IV är pågående och beskriver metoden för hur den internationella studien EPI-CT 
ämnar genomföras. EPI-CT har som mål att samla in 1 miljon barn som är undersökta med 
DT och beräkna stråldoser för att kunna undersöka sambandet mellan DT och cancer och 
leukemi hos barn. Leukemi är en sjukdom som tidigare har visats komma snart efter strålning 
och man kan därför ha en kortare uppföljningstid. 
För att undersöka sambandet mellan röntgenstrålning och negativa hälsoeffekter som cancer 
behövs lång uppföljningstid vilket dom retrospektiva studierna I-III möjliggör. Ingen av 
studierna I-III kunde påvisa negativa effekt på dom utfallen vi studerade. En möjlig orsak till 
detta kan vara att studierna har för få patienter. EPI-CT som ämnar undersöka 1 miljon 
patienter har förhoppningsvis tillräckligt många patienter för att med större säkerhet klarlägga 
om det finns risker med datortomografiundersökningar. 
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